142(top 100%)
PR articles
16.7K(top 1%)
PR citations
33(top 100%)
PR h-index
36(top 100%)
h-index
159
documents
20.9K
doc citations
3.7K
citing journals
100
times ranked

Publications

143 PR articles • 17,941 PR citations • Sorted by year • Download PDF (PDF by citations)
#ArticleIFPR CitationsLinks
1Associations of VEGF-A-Related Variants with Adolescent Cardiometabolic and Dietary Parameters
Nutrients, 2023, 15, 1884
4.76Citations (PDF)
2Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study
Metabolites, 2023, 13, 959
3.56Citations (PDF)
3The association of vascular endothelial growth factor related SNPs and circulating iron levels might depend on body mass index2.71Citations (PDF)
4Association of Dietary Patterns with MRI Markers of Hepatic Inflammation and Fibrosis in the MAST4HEALTH Study3.13Citations (PDF)
5VEGF-A-related genetic variants protect against Alzheimer’s disease
Aging, 2022, 14, 2524-2536
2.521Citations (PDF)
6Lipolysis-Stimulated Lipoprotein Receptor Acts as Sensor to Regulate ApoE Release in Astrocytes4.59Citations (PDF)
7Functional Impairment of Endothelial Colony Forming Cells (ECFC) in Patients with Severe Atherosclerotic Cardiovascular Disease (ASCVD)4.517Citations (PDF)
8Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability13.9132Citations (PDF)
9Genome-wide association study of circulating interleukin 6 levels identifies novel loci
Human Molecular Genetics, 2021, 30, 393-409
3.052Citations (PDF)
10Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial4.131Citations (PDF)
11Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD5.123Citations (PDF)
12Epigenome-wide association study detects a novel loci associated with central obesity in healthy subjects1.86Citations (PDF)
13Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Lancet, The, 2021, 398, 957-980
52.82,827Citations (PDF)
14Dietary Patterns, Blood Pressure and the Glycemic and Lipidemic Profile of Two Teenage, European Populations
Nutrients, 2021, 13, 198
4.710Citations (PDF)
15A genetic determinant of VEGF-A levels is associated with telomere attrition
Aging, 2021, 13, 23517-23526
2.52Citations (PDF)
16National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries5.153Citations (PDF)
17Telomere length determinants in childhood2.456Citations (PDF)
18Milestones in Personalized Medicine: From the Ancient Time to Nowadays—the Provocation of COVID-192.442Citations (PDF)
19Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants
Lancet, The, 2020, 396, 1511-1524
52.8343Citations (PDF)
20Repositioning of the global epicentre of non-optimal cholesterol
Nature, 2020, 582, 73-77
38.7237Citations (PDF)
21Epigenome-wide association study in healthy individuals identifies significant associations with DNA methylation and PBMC extract VEGF-A concentration4.09Citations (PDF)
22Increased risk of hypercholesterolemia in a French and Lebanese population due to an interaction between rs2569190 in CD14 and gender
Clinica Chimica Acta, 2020, 509, 172-176
1.61Citations (PDF)
23TERC Variants Associated with Short Leukocyte Telomeres: Implication of Higher Early Life Leukocyte Telomere Attrition as Assessed by the Blood-and-Muscle Model
Cells, 2020, 9, 1360
4.84Citations (PDF)
24Obesity status modifies the association between rs7556897T&gt;C in the intergenic region <i>SLC19A3</i>-<i>CCL20</i> and blood pressure in French children2.43Citations (PDF)
25Peripheral blood mononuclear cells extracts VEGF protein levels and VEGF mRNA: Associations with inflammatory molecules in a healthy population
PLoS ONE, 2019, 14, e0220902
2.411Citations (PDF)
264th ESPT Summer School: Precision Medicine and Personalised Health
Pharmacogenomics, 2019, 20, 471-474
1.60Citations (PDF)
27Genetic determinants of circulating haptoglobin concentration
Clinica Chimica Acta, 2019, 494, 138-142
1.617Citations (PDF)
28Epigenome-Wide Association Study (EWAS) of Blood Lipids in Healthy Population from STANISLAS Family Study (SFS)4.517Citations (PDF)
29Pleiotropy of ABO gene: correlation of rs644234 with E-selectin and lipid levels2.410Citations (PDF)
30Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: a pooled analysis of 1018 population-based measurement studies with 88.6 million participants5.176Citations (PDF)
31The Relationship Between Vascular Endothelial Growth Factor Cis- and Trans-Acting Genetic Variants and Metabolic Syndrome0.88Citations (PDF)
32Effect of <i>LSR</i> polymorphism on blood lipid levels and age‐specific epistatic interaction with the <i>APOE</i> common polymorphism
Clinical Genetics, 2018, 93, 846-852
2.15Citations (PDF)
33A transnational collaborative network dedicated to the study and applications of the vascular endothelial growth factor-A in medical practice: the VEGF Consortium2.41Citations (PDF)
34VEGF-A is associated with early degenerative changes in cartilage and subchondral bone
Growth Factors, 2018, 36, 263-273
1.818Citations (PDF)
35Personalised Medicine: The Odyssey from Hope to Practice2.610Citations (PDF)
36Genome Analyses of &gt;200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders6.5416Citations (PDF)
37The future of telomere length in personalized medicine6.035Citations (PDF)
38The polymorphism rs6918289 located in the downstream region of the TREM2 gene is associated with TNF-α levels and IMT-F3.53Citations (PDF)
39Epistatic interaction of apolipoprotein E and lipolysis-stimulated lipoprotein receptor genetic variants is associated with Alzheimer's disease
Neurobiology of Aging, 2018, 69, 292.e1-292.e5
3.44Citations (PDF)
40VEGF-related polymorphisms identified by GWAS and risk for major depression
Translational Psychiatry, 2017, 7, e1055-e1055
5.546Citations (PDF)
418th Santorini Conference: Systems medicine and personalized health and therapy, Santorini, Greece, 3–5 October 20161.05Citations (PDF)
42Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
Lancet, The, 2017, 390, 2627-2642
52.86,316Citations (PDF)
43Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma2.41Citations (PDF)
44IL6R haplotype rs4845625*T/rs4537545*C is a risk factor for simultaneously high CRP, LDL and ApoB levels
Genes and Immunity, 2017, 18, 163-169
3.87Citations (PDF)
45Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
Lancet, The, 2017, 389, 37-55
52.82,027Citations (PDF)
46Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice2.39Citations (PDF)
47TREM-1 SNP rs2234246 regulates TREM-1 protein and mRNA levels and is associated with plasma levels of L-selectin
PLoS ONE, 2017, 12, e0182226
2.434Citations (PDF)
48La Pharmacogénomique, meilleur exemple de médecine personnalisée0.10Citations (PDF)
49Cardiovascular diseases-related GNB3 C825T polymorphism has a significant sex-specific effect on serum soluble E-selectin levels4.16Citations (PDF)
50Pro- and anti-angiogenic VEGF mRNAs in autoimmune thyroid diseases
Autoimmunity, 2016, 49, 366-372
3.27Citations (PDF)
51Plasma VEGF-related polymorphisms are implied in autoimmune thyroid diseases
Autoimmunity, 2016, 49, 229-235
3.28Citations (PDF)
52Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association Studies
PLoS Genetics, 2016, 12, e1005874
3.362Citations (PDF)
53De l’écogénétique à la pharmacogénomique par le stress oxydant0.10Citations (PDF)
54Le Professeur Gérard Siest nous a quittés (1936-2016)0.10Citations (PDF)
55Angiogenesis related genes NOS3, CD14, MMP3 and IL4R are associated to VEGF gene expression and circulating levels in healthy adults2.032Citations (PDF)
56Genetic Determined Low Response to Thienopyridines is Associated with Higher Systemic Inflammation in Smokers
Pharmacogenomics, 2015, 16, 459-469
1.60Citations (PDF)
57Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids
Drug Metabolism Reviews, 2014, 46, 33-56
3.932Citations (PDF)
58Human cytochrome P450 epoxygenases: Variability in expression and role in inflammation-related disorders
2014, 144, 134-161
90Citations (PDF)
59Epistatic study reveals two genetic interactions in blood pressure regulation2.013Citations (PDF)
60Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population
Cytokine, 2013, 61, 602-607
3.733Citations (PDF)
61Dairy product consumption, calcium intakes, and metabolic syndrome–related factors over 5 years in the STANISLAS study
Nutrition, 2013, 29, 519-524
2.964Citations (PDF)
62Relationship between catalase haplotype and arterial aging
Atherosclerosis, 2013, 227, 100-105
1.614Citations (PDF)
63Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs42442852.34Citations (PDF)
64A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C
Journal of Lipid Research, 2013, 54, 535-541
3.730Citations (PDF)
65What Is the Contribution of Two Genetic Variants Regulating VEGF Levels to Type 2 Diabetes Risk and to Microvascular Complications?
PLoS ONE, 2013, 8, e55921
2.439Citations (PDF)
66Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals
PLoS Genetics, 2012, 8, e1002607
3.3453Citations (PDF)
67Novel association approach for variable number tandem repeats (VNTRs) identifies DOCK5 as a susceptibility gene for severe obesity
Human Molecular Genetics, 2012, 21, 3727-3738
3.040Citations (PDF)
68Alcohol Consumption, Beverage Preference, and Diet in Middle-Aged Men from the STANISLAS Study2.121Citations (PDF)
69Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans
Human Molecular Genetics, 2012, 21, 5385-5394
3.0235Citations (PDF)
70Genetic biomarkers of hypertension and future challenges integrating epigenomics
Clinica Chimica Acta, 2012, 414, 259-265
1.632Citations (PDF)
71Human formyl peptide receptor 1 C32T SNP interacts with age and is associated with blood pressure levels
Clinica Chimica Acta, 2012, 413, 34-38
1.615Citations (PDF)
72Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999
Clinica Chimica Acta, 2012, 413, 1618-1624
1.616Citations (PDF)
73High Prevalence of Metabolic Syndrome in Iran in Comparison with France: What Are the Components That Explain This?2.151Citations (PDF)
74A Genome-Wide Association Search for Type 2 Diabetes Genes in African Americans
PLoS ONE, 2012, 7, e29202
2.4204Citations (PDF)
75A Genome-Wide Association Study Identifies rs2000999 as a Strong Genetic Determinant of Circulating Haptoglobin Levels
PLoS ONE, 2012, 7, e32327
2.438Citations (PDF)
76Functional Epistatic Interaction between rs6046G&gt;A in F7 and rs5355C&gt;T in SELE Modifies Systolic Blood Pressure Levels
PLoS ONE, 2012, 7, e40777
2.48Citations (PDF)
77Childhood Obesity Is Associated with Shorter Leukocyte Telomere Length4.2139Citations (PDF)
78Klotho KL-VS genotype is involved in blood pressure regulation
Clinica Chimica Acta, 2011, 412, 1773-1777
1.620Citations (PDF)
79Cardiovascular diseases and genome-wide association studies
Clinica Chimica Acta, 2011, 412, 1697-1701
1.622Citations (PDF)
80Availability of Pharmacogenetic and Pharmacogenomic Information in Anticancer Drug Monographs in France: Personalized Cancer Therapy
Pharmacogenomics, 2011, 12, 681-691
1.64Citations (PDF)
81Identification of <i>cis</i> - and <i>trans</i> -Acting Genetic Variants Explaining Up to Half the Variation in Circulating Vascular Endothelial Growth Factor Levels
Circulation Research, 2011, 109, 554-563
12.581Citations (PDF)
82Association of Genetic Loci With Glucose Levels in Childhood and Adolescence
Diabetes, 2011, 60, 1805-1812
4.4111Citations (PDF)
83Biological and genetic factors associated with ABCB1 and pregnane-X-receptor expressions in peripheral blood mononuclear cells in the STANISLAS cohort0.33Citations (PDF)
84Association Between Angiotensin II Type 1 Receptor Gene Polymorphism and Metabolic Syndrome in a Young Female Iranian Population
Archives of Medical Research, 2010, 41, 343-349
2.717Citations (PDF)
85Expression of inflammatory molecules and associations with BMI in children3.324Citations (PDF)
86Sex‐dependent Associations of Leptin With Metabolic Syndrome–related Variables: The Stanislas Study
Obesity, 2010, 18, 196-201
4.227Citations (PDF)
87Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
Nature Genetics, 2010, 42, 937-948
26.12,774Citations (PDF)
88Prevalence of Loss-of-Function FTO Mutations in Lean and Obese Individuals
Diabetes, 2010, 59, 311-318
4.498Citations (PDF)
89Metabolic syndrome-related composite factors over 5years in the STANISLAS Family Study: Genetic heritability and common environmental influences
Clinica Chimica Acta, 2010, 411, 833-839
1.615Citations (PDF)
90New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
Nature Genetics, 2010, 42, 105-116
26.12,098Citations (PDF)
91Personalized Therapy and Pharmacogenomics: Future Perspective
Pharmacogenomics, 2009, 10, 927-930
1.69Citations (PDF)
92Capillary isotachophoresis study of lipoprotein network sensitive to apolipoprotein E phenotype. 2. ApoE and apoC-III relations in triglyceride clearance3.33Citations (PDF)
93Capillary isotachophoresis study of lipoprotein network sensitive to apolipoprotein E phenotype. 1. ApoE distribution between lipoproteins3.33Citations (PDF)
94Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations
Nature Genetics, 2009, 41, 157-159
26.1609Citations (PDF)
95Association between EGF and lipid concentrations: A benefit role in the atherosclerotic process?
Clinica Chimica Acta, 2009, 402, 196-198
1.611Citations (PDF)
96Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort
Clinica Chimica Acta, 2009, 403, 198-202
1.623Citations (PDF)
97Adipokine expression in adipose tissue and in peripheral blood mononuclear cells in children
Clinica Chimica Acta, 2009, 410, 85-89
1.67Citations (PDF)
98Association of human cathelicidin (hCAP-18/LL-37) gene expression with cardiovascular disease risk factors3.432Citations (PDF)
99Human Formyl Peptide Receptor 1 ( <i>FPR1</i> ) c.32C&gt;T SNP is Associated with Decreased Soluble E-selectin Levels
Pharmacogenomics, 2009, 10, 951-959
1.68Citations (PDF)
100Parental Precocious Influences on Offspring Cardiovascular Risk Markers: An Exploratory Study in the Stanislas Cohort
Personalized Medicine, 2009, 6, 343-352
1.40Citations (PDF)
101Candidate Gene Microarray Analysis in Peripheral Blood Cells for Studying Hypertension/Obesity
Personalized Medicine, 2009, 6, 269-291
1.46Citations (PDF)
102Drug Metabolizing Enzymes and Transporters mRNA in Peripheral Blood Mononuclear Cells of Healthy Subjects: Biological Variations and Importance of Preanalytical Steps
Current Drug Metabolism, 2009, 10, 410-419
1.25Citations (PDF)
103Genomics and the Prospects of Existing and Emerging Therapeutics for Cardiovascular Diseases
Current Pharmaceutical Design, 2009, 15, 3193-3206
2.412Citations (PDF)
104Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study3.227Citations (PDF)
105Visfatin, low‐grade inflammation and body mass index (BMI)
Clinical Endocrinology, 2008, 69, 568-574
2.540Citations (PDF)
106Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: Review and hypothesis
Vascular Pharmacology, 2008, 48, 70-75
2.510Citations (PDF)
107Leptin expression in Peripheral Blood Mononuclear Cells (PBMCs) is related with blood pressure variability
Clinica Chimica Acta, 2008, 395, 47-50
1.616Citations (PDF)
108Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects3.681Citations (PDF)
109A new single nucleotide polymorphism genotyping method based on gap ligase chain reaction and a microsphere detection assay2.44Citations (PDF)
110The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases2.451Citations (PDF)
111Genetic profiling in healthy subjects from the Stanislas cohort based on 24 polymorphisms: effects on biological variables2.41Citations (PDF)
112Genetic profiling of human cell lines used as in vitro model to study cardiovascular pathophysiology and pharmacotoxicology
Cell Biology and Toxicology, 2008, 25, 561-571
5.08Citations (PDF)
113Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort2.411Citations (PDF)
114Effect of HMGCoA Reductase Inhibitors on Cytochrome P450 Expression in Endothelial Cell Line2.123Citations (PDF)
115Enzymes and pharmacogenetics of cardiovascular drugs
Clinica Chimica Acta, 2007, 381, 26-31
1.640Citations (PDF)
116Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort
Atherosclerosis, 2007, 191, 369-376
1.615Citations (PDF)
117Association between TNF and IL-1 bloc polymorphisms and plasma MCP-1 concentration
Atherosclerosis, 2007, 192, 348-353
1.612Citations (PDF)
118Pharmacogenomics and antihypertensive drugs: a path toward personalized medicine
Personalized Medicine, 2007, 4, 393-412
1.44Citations (PDF)
119Une étude prospective de la prévalence du syndrome métabolique dans des familles françaises supposées saines1.11Citations (PDF)
120Pharmacogénomique et pharmacoprotéomique1.17Citations (PDF)
121Peripheral blood mononuclear cells (PBMCs): a possible model for studying cardiovascular biology systems2.458Citations (PDF)
122Variations pré-analytiques des biomarqueursprotéiques
Medecine/Sciences, 2007, 23, 9-12
0.22Citations (PDF)
123Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles
Genes and Immunity, 2007, 8, 352-359
3.812Citations (PDF)
124Lack of Association between EGF 61A>G Polymorphism and Plasma EGF Concentration in the STANISLAS Family Study2.33Citations (PDF)
125Heritability for Plasma VEGF Concentration in the Stanislas Family Study
Annals of Human Genetics, 2007, 71, 54-63
1.234Citations (PDF)
126Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population2.542Citations (PDF)
127Genetic and environmental contributions to serum ascorbic acid concentrations: the Stanislas Family Study
British Journal of Nutrition, 2006, 96, 1013-1020
2.52Citations (PDF)
128Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort
Journal of Hypertension, 2006, 24, 2199-2205
2.321Citations (PDF)
129Genetic variants predisposing to cardiovascular disease4.148Citations (PDF)
130Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia2.812Citations (PDF)
131Biological Determinants of and Reference Values for Plasma Interleukin-8, Monocyte Chemoattractant Protein-1, Epidermal Growth Factor, and Vascular Endothelial Growth Factor: Results from the STANISLAS Cohort
Clinical Chemistry, 2006, 52, 504-510
1.155Citations (PDF)
132Polymorphisms associated with apolipoprotein B levels in Greek patients with familial hypercholesterolemia2.43Citations (PDF)
133Different Genes and Polymorphisms Affecting High-Density Lipoprotein Cholesterol Levels in Greek Familial Hypercholesterolemia Patients0.010Citations (PDF)
134E‐Selectin Genotypes and Risk of Type 2 Diabetes in Women: Genetic and Environmental Contributions to Serum Soluble E‐Selectin Concentrations
Obesity, 2005, 13, 1845-1847
4.25Citations (PDF)
135Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort
Pharmacogenomics Journal, 2005, 5, 271-275
2.836Citations (PDF)
136Pharmacogenomics and cardiovascular drugs: Need for integrated biological system with phenotypes and proteomic markers4.433Citations (PDF)
137Apolipoprotein E polymorphism is not associated with lipid levels and coronary artery disease in Greek patients with familial hypercholesterolaemia3.020Citations (PDF)
138Polymorphism of the 5-HT2A receptor gene and food intakes in children and adolescents: the Stanislas Family Study4.932Citations (PDF)
139Collection and Storage of Human Blood Cells for mRNA Expression Profiling: A 15-Month Stability Study
Clinical Chemistry, 2005, 51, 1250-1252
1.137Citations (PDF)
140Inter-individual variation of inflammatory markers of cardiovascular risks and diseases2.418Citations (PDF)
141Down-regulation of astroglial CYP2C, glucocorticoid receptor and constitutive androstane receptor genes in response to cocaine in human U373 MG astrocytoma cells
Toxicology Letters, 2005, 159, 203-211
0.625Citations (PDF)
142Association Between Factor VII Polymorphisms and Blood Pressure
Hypertension, 2004, 44, 674-680
6.98Citations (PDF)
143Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
ELife, 0, 10,
1.664Citations (PDF)